APO Research
Talk to an analyst

APO RESEARCH · REPORT

Everolimus Eluting Stent

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Everolimus Eluting Stent Market Analysis and Forecast 2026-2032

25 December 2025191 pages

Choose your research edition.

Industry ResearchEverolimus Eluting Stent Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Everolimus Eluting Stent Industry Growth and Trends Forecast to 203270 pages · $3,450 USDMarket StructureGlobal Everolimus Eluting Stent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Everolimus Eluting Stent Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Everolimus Eluting Stent Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Everolimus Eluting Stent market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Everolimus Eluting Stent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Everolimus Eluting Stent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Everolimus Eluting Stent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Everolimus Eluting Stent is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Everolimus Eluting Stent include Boston Scientific and Abbott etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Everolimus Eluting Stent, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Everolimus Eluting Stent, also provides the sales of main regions and countries. Of the upcoming market potential for Everolimus Eluting Stent, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Everolimus Eluting Stent sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Everolimus Eluting Stent market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Everolimus Eluting Stent sales, projected growth trends, production technology, application and end-user industry.

Everolimus Eluting Stent Segment by Company

Boston Scientific

Abbott

Everolimus Eluting Stent Segment by Type

PLGA Polymer Coating

Fluoropolymer Coating

Everolimus Eluting Stent Segment by Application

Hospital

Clinic

Others

Everolimus Eluting Stent Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Everolimus Eluting Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Everolimus Eluting Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Everolimus Eluting Stent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Everolimus Eluting Stent in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Everolimus Eluting Stent manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Everolimus Eluting Stent sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Everolimus Eluting Stent Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. PLGA Polymer Coating Major Manufacturers Table 3. Fluoropolymer Coating Major Manufacturers Table 4. Global Everolimus Eluting Stent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Clinic Major Manufacturers Table 7. Others Major Manufacturers Table 8. Everolimus Eluting Stent Industry Trends Table 9. Everolimus Eluting Stent Industry Drivers Table 10. Everolimus Eluting Stent Industry Opportunities and Challenges Table 11. Everolimus Eluting Stent Industry Restraints Table 12. Global Everolimus Eluting Stent Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Everolimus Eluting Stent Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Everolimus Eluting Stent Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Everolimus Eluting Stent Revenue Market Share by Region (2021-2026) Table 16. Global Everolimus Eluting Stent Revenue Market Share by Region (2027-2032) Table 17. Global Everolimus Eluting Stent Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Everolimus Eluting Stent Sales by Region (2021-2026) & (K Units) Table 19. Global Everolimus Eluting Stent Sales by Region (2027-2032) & (K Units) Table 20. Global Everolimus Eluting Stent Sales Market Share by Region (2021-2026) Table 21. Global Everolimus Eluting Stent Sales Market Share by Region (2027-2032) Table 22. Global Everolimus Eluting Stent Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Everolimus Eluting Stent Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Everolimus Eluting Stent Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Everolimus Eluting Stent Sales Market Share by Manufacturers (2021-2026) Table 26. Global Everolimus Eluting Stent Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Everolimus Eluting Stent Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Everolimus Eluting Stent Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Everolimus Eluting Stent Manufacturers, Product Type & Application Table 30. Global Everolimus Eluting Stent Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Everolimus Eluting Stent by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Everolimus Eluting Stent Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Everolimus Eluting Stent Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Everolimus Eluting Stent Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Everolimus Eluting Stent Revenue Market Share by Type (2021-2026) Table 37. Global Everolimus Eluting Stent Revenue Market Share by Type (2027-2032) Table 38. Global Everolimus Eluting Stent Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Everolimus Eluting Stent Sales by Type (2021-2026) & (K Units) Table 40. Global Everolimus Eluting Stent Sales by Type (2027-2032) & (K Units) Table 41. Global Everolimus Eluting Stent Sales Market Share by Type (2021-2026) Table 42. Global Everolimus Eluting Stent Sales Market Share by Type (2027-2032) Table 43. Global Everolimus Eluting Stent Price by Type (2021-2026) & (US$/Unit) Table 44. Global Everolimus Eluting Stent Price by Type (2027-2032) & (US$/Unit) Table 45. Global Everolimus Eluting Stent Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Everolimus Eluting Stent Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Everolimus Eluting Stent Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Everolimus Eluting Stent Revenue Market Share by Application (2021-2026) Table 49. Global Everolimus Eluting Stent Revenue Market Share by Application (2027-2032) Table 50. Global Everolimus Eluting Stent Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Everolimus Eluting Stent Sales by Application (2021-2026) & (K Units) Table 52. Global Everolimus Eluting Stent Sales by Application (2027-2032) & (K Units) Table 53. Global Everolimus Eluting Stent Sales Market Share by Application (2021-2026) Table 54. Global Everolimus Eluting Stent Sales Market Share by Application (2027-2032) Table 55. Global Everolimus Eluting Stent Price by Application (2021-2026) & (US$/Unit) Table 56. Global Everolimus Eluting Stent Price by Application (2027-2032) & (US$/Unit) Table 57. Boston Scientific Company Information Table 58. Boston Scientific Business Overview Table 59. Boston Scientific Everolimus Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Boston Scientific Everolimus Eluting Stent Product Portfolio Table 61. Boston Scientific Recent Development Table 62. Abbott Company Information Table 63. Abbott Business Overview Table 64. Abbott Everolimus Eluting Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Abbott Everolimus Eluting Stent Product Portfolio Table 66. Abbott Recent Development Table 67. North America Everolimus Eluting Stent Revenue by Type (2021-2026) & (US$ Million) Table 68. North America Everolimus Eluting Stent Revenue by Type (2027-2032) & (US$ Million) Table 69. North America Everolimus Eluting Stent Sales by Type (2021-2026) & (K Units) Table 70. North America Everolimus Eluting Stent Sales by Type (2027-2032) & (K Units) Table 71. North America Everolimus Eluting Stent Sales Price by Type (2021-2026) & (US$/Unit) Table 72. North America Everolimus Eluting Stent Sales Price by Type (2027-2032) & (US$/Unit) Table 73. North America Everolimus Eluting Stent Revenue by Application (2021-2026) & (US$ Million) Table 74. North America Everolimus Eluting Stent Revenue by Application (2027-2032) & (US$ Million) Table 75. North America Everolimus Eluting Stent Sales by Application (2021-2026) & (K Units) Table 76. North America Everolimus Eluting Stent Sales by Application (2027-2032) & (K Units) Table 77. North America Everolimus Eluting Stent Sales Price by Application (2021-2026) & (US$/Unit) Table 78. North America Everolimus Eluting Stent Sales Price by Application (2027-2032) & (US$/Unit) Table 79. North America Everolimus Eluting Stent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 80. North America Everolimus Eluting Stent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 81. North America Everolimus Eluting Stent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 82. North America Everolimus Eluting Stent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 83. North America Everolimus Eluting Stent Sales by Country (2021-2026) & (K Units) Table 84. North America Everolimus Eluting Stent Sales by Country (2027-2032) & (K Units) Table 85. North America Everolimus Eluting Stent Sales Price by Country (2021-2026) & (US$/Unit) Table 86. North America Everolimus Eluting Stent Sales Price by Country (2027-2032) & (US$/Unit) Table 87. United States Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 88. Canada Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 89. Mexico Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 90. Europe Everolimus Eluting Stent Revenue by Type (2021-2026) & (US$ Million) Table 91. Europe Everolimus Eluting Stent Revenue by Type (2027-2032) & (US$ Million) Table 92. Europe Everolimus Eluting Stent Sales by Type (2021-2026) & (K Units) Table 93. Europe Everolimus Eluting Stent Sales by Type (2027-2032) & (K Units) Table 94. Europe Everolimus Eluting Stent Sales Price by Type (2021-2026) & (US$/Unit) Table 95. Europe Everolimus Eluting Stent Sales Price by Type (2027-2032) & (US$/Unit) Table 96. Europe Everolimus Eluting Stent Revenue by Application (2021-2026) & (US$ Million) Table 97. Europe Everolimus Eluting Stent Revenue by Application (2027-2032) & (US$ Million) Table 98. Europe Everolimus Eluting Stent Sales by Application (2021-2026) & (K Units) Table 99. Europe Everolimus Eluting Stent Sales by Application (2027-2032) & (K Units) Table 100. Europe Everolimus Eluting Stent Sales Price by Application (2021-2026) & (US$/Unit) Table 101. Europe Everolimus Eluting Stent Sales Price by Application (2027-2032) & (US$/Unit) Table 102. Europe Everolimus Eluting Stent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 103. Europe Everolimus Eluting Stent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 104. Europe Everolimus Eluting Stent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 105. Europe Everolimus Eluting Stent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 106. Europe Everolimus Eluting Stent Sales by Country (2021-2026) & (K Units) Table 107. Europe Everolimus Eluting Stent Sales by Country (2027-2032) & (K Units) Table 108. Europe Everolimus Eluting Stent Sales Price by Country (2021-2026) & (US$/Unit) Table 109. Europe Everolimus Eluting Stent Sales Price by Country (2027-2032) & (US$/Unit) Table 110. Germany Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 111. France Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 112. U.K. Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 113. Italy Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 114. Russia Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 115. Spain Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 116. Netherlands Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 117. Switzerland Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 118. Sweden Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 119. Poland Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 120. China Everolimus Eluting Stent Revenue by Type (2021-2026) & (US$ Million) Table 121. China Everolimus Eluting Stent Revenue by Type (2027-2032) & (US$ Million) Table 122. China Everolimus Eluting Stent Sales by Type (2021-2026) & (K Units) Table 123. China Everolimus Eluting Stent Sales by Type (2027-2032) & (K Units) Table 124. China Everolimus Eluting Stent Sales Price by Type (2021-2026) & (US$/Unit) Table 125. China Everolimus Eluting Stent Sales Price by Type (2027-2032) & (US$/Unit) Table 126. China Everolimus Eluting Stent Revenue by Application (2021-2026) & (US$ Million) Table 127. China Everolimus Eluting Stent Revenue by Application (2027-2032) & (US$ Million) Table 128. China Everolimus Eluting Stent Sales by Application (2021-2026) & (K Units) Table 129. China Everolimus Eluting Stent Sales by Application (2027-2032) & (K Units) Table 130. China Everolimus Eluting Stent Sales Price by Application (2021-2026) & (US$/Unit) Table 131. China Everolimus Eluting Stent Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Asia Everolimus Eluting Stent Revenue by Type (2021-2026) & (US$ Million) Table 133. Asia Everolimus Eluting Stent Revenue by Type (2027-2032) & (US$ Million) Table 134. Asia Everolimus Eluting Stent Sales by Type (2021-2026) & (K Units) Table 135. Asia Everolimus Eluting Stent Sales by Type (2027-2032) & (K Units) Table 136. Asia Everolimus Eluting Stent Sales Price by Type (2021-2026) & (US$/Unit) Table 137. Asia Everolimus Eluting Stent Sales Price by Type (2027-2032) & (US$/Unit) Table 138. Asia Everolimus Eluting Stent Revenue by Application (2021-2026) & (US$ Million) Table 139. Asia Everolimus Eluting Stent Revenue by Application (2027-2032) & (US$ Million) Table 140. Asia Everolimus Eluting Stent Sales by Application (2021-2026) & (K Units) Table 141. Asia Everolimus Eluting Stent Sales by Application (2027-2032) & (K Units) Table 142. Asia Everolimus Eluting Stent Sales Price by Application (2021-2026) & (US$/Unit) Table 143. Asia Everolimus Eluting Stent Sales Price by Application (2027-2032) & (US$/Unit) Table 144. Asia Everolimus Eluting Stent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Asia Everolimus Eluting Stent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 146. Asia Everolimus Eluting Stent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 147. Asia Everolimus Eluting Stent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 148. Asia Everolimus Eluting Stent Sales by Country (2021-2026) & (K Units) Table 149. Asia Everolimus Eluting Stent Sales by Country (2027-2032) & (K Units) Table 150. Asia Everolimus Eluting Stent Sales Price by Country (2021-2026) & (US$/Unit) Table 151. Asia Everolimus Eluting Stent Sales Price by Country (2027-2032) & (US$/Unit) Table 152. Japan Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 153. South Korea Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 154. India Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 155. Australia Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 156. Taiwan Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 157. Southeast Asia Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 158. SAMEA Everolimus Eluting Stent Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA Everolimus Eluting Stent Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA Everolimus Eluting Stent Sales by Type (2021-2026) & (K Units) Table 161. SAMEA Everolimus Eluting Stent Sales by Type (2027-2032) & (K Units) Table 162. SAMEA Everolimus Eluting Stent Sales Price by Type (2021-2026) & (US$/Unit) Table 163. SAMEA Everolimus Eluting Stent Sales Price by Type (2027-2032) & (US$/Unit) Table 164. SAMEA Everolimus Eluting Stent Revenue by Application (2021-2026) & (US$ Million) Table 165. SAMEA Everolimus Eluting Stent Revenue by Application (2027-2032) & (US$ Million) Table 166. SAMEA Everolimus Eluting Stent Sales by Application (2021-2026) & (K Units) Table 167. SAMEA Everolimus Eluting Stent Sales by Application (2027-2032) & (K Units) Table 168. SAMEA Everolimus Eluting Stent Sales Price by Application (2021-2026) & (US$/Unit) Table 169. SAMEA Everolimus Eluting Stent Sales Price by Application (2027-2032) & (US$/Unit) Table 170. SAMEA Everolimus Eluting Stent Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. SAMEA Everolimus Eluting Stent Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. SAMEA Everolimus Eluting Stent Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. SAMEA Everolimus Eluting Stent Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 174. SAMEA Everolimus Eluting Stent Sales by Country (2021-2026) & (K Units) Table 175. SAMEA Everolimus Eluting Stent Sales by Country (2027-2032) & (K Units) Table 176. SAMEA Everolimus Eluting Stent Sales Price by Country (2021-2026) & (US$/Unit) Table 177. SAMEA Everolimus Eluting Stent Sales Price by Country (2027-2032) & (US$/Unit) Table 178. Brazil Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 179. Argentina Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 180. Chile Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 181. Colombia Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 182. Peru Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 183. Saudi Arabia Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 184. Israel Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 185. UAE Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 186. Turkey Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 187. Iran Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 188. Egypt Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Table 189. Key Raw Materials Table 190. Raw Materials Key Suppliers Table 191. Everolimus Eluting Stent Distributors List Table 192. Everolimus Eluting Stent Customers List Table 193. Research Programs/Design for This Report Table 194. Authors List of This Report Table 195. Secondary Sources Table 196. Primary Sources List of Figures Figure 1. Everolimus Eluting Stent Image Figure 2. Global Everolimus Eluting Stent Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Everolimus Eluting Stent Market Size Share 2021 VS 2025 VS 2032 Figure 4. PLGA Polymer Coating Image Figure 5. Fluoropolymer Coating Image Figure 6. Global Everolimus Eluting Stent Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Everolimus Eluting Stent Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Clinic Image Figure 10. Others Image Figure 11. Global Everolimus Eluting Stent Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Everolimus Eluting Stent Revenue (2021-2032) & (US$ Million) Figure 13. Global Everolimus Eluting Stent Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Everolimus Eluting Stent Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Everolimus Eluting Stent Revenue Market Share by Region (2021-2032) Figure 16. Global Everolimus Eluting Stent Sales (2021-2032) & (K Units) Figure 17. Global Everolimus Eluting Stent Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Everolimus Eluting Stent Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Everolimus Eluting Stent Sales YoY (2021-2032) & (K Units) Figure 20. Europe Everolimus Eluting Stent Sales YoY (2021-2032) & (K Units) Figure 21. China Everolimus Eluting Stent Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Everolimus Eluting Stent Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Everolimus Eluting Stent Sales YoY (2021-2032) & (K Units) Figure 24. Global Everolimus Eluting Stent Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Everolimus Eluting Stent Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Everolimus Eluting Stent Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Everolimus Eluting Stent Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Everolimus Eluting Stent Revenue Market Share by Type (2021-2032) Figure 30. Global Everolimus Eluting Stent Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Everolimus Eluting Stent Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Everolimus Eluting Stent Sales Market Share by Type (2021-2032) Figure 33. Global Everolimus Eluting Stent Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Everolimus Eluting Stent Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Everolimus Eluting Stent Revenue Market Share by Application (2021-2032) Figure 36. Global Everolimus Eluting Stent Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Everolimus Eluting Stent Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Everolimus Eluting Stent Sales Market Share by Application (2021-2032) Figure 39. North America Everolimus Eluting Stent Revenue Share by Type (2021-2032) Figure 40. North America Everolimus Eluting Stent Sales Share by Type (2021-2032) Figure 41. North America Everolimus Eluting Stent Revenue Share by Application (2021-2032) Figure 42. North America Everolimus Eluting Stent Sales Share by Application (2021-2032) Figure 43. North America Everolimus Eluting Stent Revenue Share by Country (2021-2032) Figure 44. North America Everolimus Eluting Stent Sales Share by Country (2021-2032) Figure 45. Europe Everolimus Eluting Stent Revenue Share by Type (2021-2032) Figure 46. Europe Everolimus Eluting Stent Sales Share by Type (2021-2032) Figure 47. Europe Everolimus Eluting Stent Revenue Share by Application (2021-2032) Figure 48. Europe Everolimus Eluting Stent Sales Share by Application (2021-2032) Figure 49. Europe Everolimus Eluting Stent Revenue Share by Country (2021-2032) Figure 50. Europe Everolimus Eluting Stent Sales Share by Country (2021-2032) Figure 51. China Everolimus Eluting Stent Revenue Share by Type (2021-2032) Figure 52. China Everolimus Eluting Stent Sales Share by Type (2021-2032) Figure 53. China Everolimus Eluting Stent Revenue Share by Application (2021-2032) Figure 54. China Everolimus Eluting Stent Sales Share by Application (2021-2032) Figure 55. Asia Everolimus Eluting Stent Revenue Share by Type (2021-2032) Figure 56. Asia Everolimus Eluting Stent Sales Share by Type (2021-2032) Figure 57. Asia Everolimus Eluting Stent Revenue Share by Application (2021-2032) Figure 58. Asia Everolimus Eluting Stent Sales Share by Application (2021-2032) Figure 59. Asia Everolimus Eluting Stent Revenue Share by Country (2021-2032) Figure 60. Asia Everolimus Eluting Stent Sales Share by Country (2021-2032) Figure 61. SAMEA Everolimus Eluting Stent Revenue Share by Type (2021-2032) Figure 62. SAMEA Everolimus Eluting Stent Sales Share by Type (2021-2032) Figure 63. SAMEA Everolimus Eluting Stent Revenue Share by Application (2021-2032) Figure 64. SAMEA Everolimus Eluting Stent Sales Share by Application (2021-2032) Figure 65. SAMEA Everolimus Eluting Stent Revenue Share by Country (2021-2032) Figure 66. SAMEA Everolimus Eluting Stent Sales Share by Country (2021-2032) Figure 67. Everolimus Eluting Stent Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Everolimus Eluting Stent Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • PLGA Polymer Coating
  • Fluoropolymer Coating
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Boston Scientific
  • Abbott

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Everolimus Eluting Stent Market by Type
  3. 1.2.1 Global Everolimus Eluting Stent Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 PLGA Polymer Coating
  5. 1.2.3 Fluoropolymer Coating
  6. 1.3 Everolimus Eluting Stent Market by Application
  7. 1.3.1 Global Everolimus Eluting Stent Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Clinic
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Everolimus Eluting Stent Market Dynamics
  1. 2.1 Everolimus Eluting Stent Industry Trends
  2. 2.2 Everolimus Eluting Stent Industry Drivers
  3. 2.3 Everolimus Eluting Stent Industry Opportunities and Challenges
  4. 2.4 Everolimus Eluting Stent Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Everolimus Eluting Stent Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Everolimus Eluting Stent Revenue by Region
  3. 3.2.1 Global Everolimus Eluting Stent Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Everolimus Eluting Stent Revenue by Region (2021-2026)
  5. 3.2.3 Global Everolimus Eluting Stent Revenue by Region (2027-2032)
  6. 3.2.4 Global Everolimus Eluting Stent Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Everolimus Eluting Stent Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Everolimus Eluting Stent Sales by Region
  9. 3.4.1 Global Everolimus Eluting Stent Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Everolimus Eluting Stent Sales by Region (2021-2026)
  11. 3.4.3 Global Everolimus Eluting Stent Sales by Region (2027-2032)
  12. 3.4.4 Global Everolimus Eluting Stent Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Everolimus Eluting Stent Revenue by Manufacturers
  2. 4.1.1 Global Everolimus Eluting Stent Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Everolimus Eluting Stent Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Everolimus Eluting Stent Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Everolimus Eluting Stent Sales by Manufacturers
  6. 4.2.1 Global Everolimus Eluting Stent Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Everolimus Eluting Stent Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Everolimus Eluting Stent Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Everolimus Eluting Stent Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Everolimus Eluting Stent Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Everolimus Eluting Stent Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Everolimus Eluting Stent Manufacturers, Product Type & Application
  13. 4.7 Global Everolimus Eluting Stent Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Everolimus Eluting Stent Market CR5 and HHI
  16. 4.8.2 2025 Everolimus Eluting Stent Tier 1, Tier 2, and Tier 3
5 Everolimus Eluting Stent Market by Type
  1. 5.1 Global Everolimus Eluting Stent Revenue by Type
  2. 5.1.1 Global Everolimus Eluting Stent Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Everolimus Eluting Stent Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Everolimus Eluting Stent Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Everolimus Eluting Stent Sales by Type
  6. 5.2.1 Global Everolimus Eluting Stent Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Everolimus Eluting Stent Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Everolimus Eluting Stent Sales Market Share by Type (2021-2032)
  9. 5.3 Global Everolimus Eluting Stent Price by Type
6 Everolimus Eluting Stent Market by Application
  1. 6.1 Global Everolimus Eluting Stent Revenue by Application
  2. 6.1.1 Global Everolimus Eluting Stent Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Everolimus Eluting Stent Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Everolimus Eluting Stent Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Everolimus Eluting Stent Sales by Application
  6. 6.2.1 Global Everolimus Eluting Stent Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Everolimus Eluting Stent Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Everolimus Eluting Stent Sales Market Share by Application (2021-2032)
  9. 6.3 Global Everolimus Eluting Stent Price by Application
7 Company Profiles
  1. 7.1 Boston Scientific
  2. 7.1.1 Boston Scientific Company Information
  3. 7.1.2 Boston Scientific Business Overview
  4. 7.1.3 Boston Scientific Everolimus Eluting Stent Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Boston Scientific Everolimus Eluting Stent Product Portfolio
  6. 7.1.5 Boston Scientific Recent Developments
  7. 7.2 Abbott
  8. 7.2.1 Abbott Company Information
  9. 7.2.2 Abbott Business Overview
  10. 7.2.3 Abbott Everolimus Eluting Stent Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Abbott Everolimus Eluting Stent Product Portfolio
  12. 7.2.5 Abbott Recent Developments
8 North America
  1. 8.1 North America Everolimus Eluting Stent Market Size by Type
  2. 8.1.1 North America Everolimus Eluting Stent Revenue by Type (2021-2032)
  3. 8.1.2 North America Everolimus Eluting Stent Sales by Type (2021-2032)
  4. 8.1.3 North America Everolimus Eluting Stent Price by Type (2021-2032)
  5. 8.2 North America Everolimus Eluting Stent Market Size by Application
  6. 8.2.1 North America Everolimus Eluting Stent Revenue by Application (2021-2032)
  7. 8.2.2 North America Everolimus Eluting Stent Sales by Application (2021-2032)
  8. 8.2.3 North America Everolimus Eluting Stent Price by Application (2021-2032)
  9. 8.3 North America Everolimus Eluting Stent Market Size by Country
  10. 8.3.1 North America Everolimus Eluting Stent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Everolimus Eluting Stent Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Everolimus Eluting Stent Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Everolimus Eluting Stent Market Size by Type
  2. 9.1.1 Europe Everolimus Eluting Stent Revenue by Type (2021-2032)
  3. 9.1.2 Europe Everolimus Eluting Stent Sales by Type (2021-2032)
  4. 9.1.3 Europe Everolimus Eluting Stent Price by Type (2021-2032)
  5. 9.2 Europe Everolimus Eluting Stent Market Size by Application
  6. 9.2.1 Europe Everolimus Eluting Stent Revenue by Application (2021-2032)
  7. 9.2.2 Europe Everolimus Eluting Stent Sales by Application (2021-2032)
  8. 9.2.3 Europe Everolimus Eluting Stent Price by Application (2021-2032)
  9. 9.3 Europe Everolimus Eluting Stent Market Size by Country
  10. 9.3.1 Europe Everolimus Eluting Stent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Everolimus Eluting Stent Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Everolimus Eluting Stent Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Everolimus Eluting Stent Market Size by Type
  2. 10.1.1 China Everolimus Eluting Stent Revenue by Type (2021-2032)
  3. 10.1.2 China Everolimus Eluting Stent Sales by Type (2021-2032)
  4. 10.1.3 China Everolimus Eluting Stent Price by Type (2021-2032)
  5. 10.2 China Everolimus Eluting Stent Market Size by Application
  6. 10.2.1 China Everolimus Eluting Stent Revenue by Application (2021-2032)
  7. 10.2.2 China Everolimus Eluting Stent Sales by Application (2021-2032)
  8. 10.2.3 China Everolimus Eluting Stent Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Everolimus Eluting Stent Market Size by Type
  2. 11.1.1 Asia Everolimus Eluting Stent Revenue by Type (2021-2032)
  3. 11.1.2 Asia Everolimus Eluting Stent Sales by Type (2021-2032)
  4. 11.1.3 Asia Everolimus Eluting Stent Price by Type (2021-2032)
  5. 11.2 Asia Everolimus Eluting Stent Market Size by Application
  6. 11.2.1 Asia Everolimus Eluting Stent Revenue by Application (2021-2032)
  7. 11.2.2 Asia Everolimus Eluting Stent Sales by Application (2021-2032)
  8. 11.2.3 Asia Everolimus Eluting Stent Price by Application (2021-2032)
  9. 11.3 Asia Everolimus Eluting Stent Market Size by Country
  10. 11.3.1 Asia Everolimus Eluting Stent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Everolimus Eluting Stent Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Everolimus Eluting Stent Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Everolimus Eluting Stent Market Size by Type
  2. 12.1.1 SAMEA Everolimus Eluting Stent Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Everolimus Eluting Stent Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Everolimus Eluting Stent Price by Type (2021-2032)
  5. 12.2 SAMEA Everolimus Eluting Stent Market Size by Application
  6. 12.2.1 SAMEA Everolimus Eluting Stent Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Everolimus Eluting Stent Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Everolimus Eluting Stent Price by Application (2021-2032)
  9. 12.3 SAMEA Everolimus Eluting Stent Market Size by Country
  10. 12.3.1 SAMEA Everolimus Eluting Stent Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Everolimus Eluting Stent Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Everolimus Eluting Stent Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Everolimus Eluting Stent Value Chain Analysis
  2. 13.1.1 Everolimus Eluting Stent Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Everolimus Eluting Stent Production Mode & Process
  6. 13.2 Everolimus Eluting Stent Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Everolimus Eluting Stent Distributors
  9. 13.2.3 Everolimus Eluting Stent Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst